Search by property

This page provides a simple browsing interface for finding entities described by a property and a named value. Other available search interfaces include the page property search, and the ask query builder.

List of results

• WBR0680  + (IL-2)
• WBR0853  + (IV Vancomycin for 4-6 weeks)
• WBR0372  + (IV alteplase)
• WBR0705  + (IV antiviral theraby)
• WBR1090  + (IV calcium gluconate)
• WBR0670  + (IV fluid resuscitation)
• WBR1042  + (Ibubrofen)
• WBR0384  + (Idiopathic hypercalciuria)
• WBR1101  + (Idiopathic pulmonary fibrosis)
• WBR1044  + (IgG intercellular junctions of epidermal cells)
• WBR0872  + (IgG, IgM, and C3 deposits)
• WBR0476  + (IgM antibodies against desmosomes)
• WBR0634  + (Imipenem)
• WBR0788  + (Imipramine)
• WBR231  + (Immune response mediated by CD4 and CD8 lymphocytes)
• WBR0292  + (Immune response mediated by CD4 and CD8 lymphocytes)
• WBR0267  + (Impaired myocardial contractility and hypotension may occur due to this acidosis)
• WBR0068  + (Impaired ventilation)
• WBR0078  + (Implantation on the uterine wall)
• WBR0407  + (Impotence)
• WBR284  + (Improper alignment of aorticopulmonary septum)
• WBR0681  + (Inability of T cells to reorganize actin cytoskeleton)
• WBR0328  + (Inability to open his jaw)
• WBR0536  + (Inactivation of sodium channels)
• WBR0436  + (Incomplete penetrance)

• WBR0090  + (Increase in FEV1 of 15% after giving inhaled albuterol)

• WBR0615  + (Increase in GABA)
• WBR0732  + (Increase in plasma norepinephrine levels)
• WBR0537  + (Increased HR, decreased BP, increased CBF, and increased BDm)
• WBR0864  + (Increased carbon dioxide production)
• WBR0616  + (Increased neutrophils, Increased red blood cells)
• WBR0369  + (Increased norepinephrine, Increased serotonin, Increased dopamine)
• WBR0085  + (Infant serum – VDRL)
• WBR0577  + (Inferior frontal gyrus)
• WBR0578  + (Inferior frontal gyrus)
• WBR0579  + (Inferior frontal gyrus)
• WBR0940  + (Inferior mesenteric lymph nodes)
• WBR0175  + (Inflammation exclusive to the ileum)
• WBR0602  + (Inflammatory bowel disease)
• WBR1032  + (Inflammatory myositis)
• WBR0684  + (Infliximab)
• WBR0551  + (Infraspinatus)
• WBR0643  + (Inhibit protein synthesis by inhibiting translocation of growing peptide)
• WBR0487  + (Inhibition of DNA polymerase)
• WBR0056  + (Inhibition of cell wall peptidoglycan formation by binding D-ala D-ala)
• WBR0434  + (Inhibition of dihydrofolate reductase activity)
• WBR0881  + (Inhibition of platelet aggregation)
• WBR0860  + (Inhibition of the mitochondrial ATP synthase)
• WBR0478  + (Inhibits DNA polymerase)
• WBR0157  + (Inhibits DNA polymerase)
• WBR0164  + (Inhibits DNA-dependent RNA polymerase by intercalating between cytosine and guanine nucleotides in DNA)